Pfizer said a vaccine that protects against the highly contagious Omicron variant should be ready by March, as Covid-19 hospitalizations in the U.S. reached a record high. Albert Bourla, chief executive of Pfizer (ticker: PFE ), said the pharmaceutical company and its partner BioNTech ( BNTX ) already had started manufacturing a version of the vaccine that would target both the fast-spreading Omicron strain as well as the original Covid-19 strain. Efforts to develop Omicron-targeting vaccines come as Covid-19 hospitalizations surged to a new high in the U.S., with 145,982 patients hospitalized — almost twice as many as two weeks ago. Read More...
Pfizer said a vaccine that protects against the highly contagious Omicron variant should be ready by March, as Covid-19 hospitalizations in the U.S. reached a record high. Albert Bourla, chief executive of Pfizer (ticker: PFE ), said the pharmaceutical company and its partner BioNTech ( BNTX ) already had started manufacturing a version of the vaccine that would target both the fast-spreading Omicron strain as well as the original Covid-19 strain. Efforts to develop Omicron-targeting vaccines come as Covid-19 hospitalizations surged to a new high in the U.S., with 145,982 patients hospitalized — almost twice as many as two weeks ago.
